Home > Insider Trading > Filing (0001209191-15-050300)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1388195	Pharmerica Corp	PMC	Retail-Drug Stores And Proprietary Stores (5912)	870792558

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1194422	S Gregory Weishar	1901 Campus Place Louisville KY 40299	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	Disposition	2015-06-02	15,661	$33.29	764,514	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2015-06-03	2,145	$32.75	762,369	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2015-06-03	79,344	$32.50	683,025	No	4	S	Direct
Common Stock, $0.01 Par Value	Disposition	2015-06-03	7,000	$32.62	0	No	4	S	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	1,500	Indirect	By Son

Footnotes

Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $33.25 and $33.50, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $32.50 and $32.68, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $32.62 and $32.63, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.